Maternal and neonatal outcomes with different screening strategies for gestational diabetes mellitus: a retrospective cohort study

To evaluate the effect of an expanded gestational diabetes mellitus (GDM) screening strategy on perinatal outcomes. This retrospective cohort study included gravidas screened for GDM at a single academic center. The “before” cohort (estimated due dates (EDD) March 2018–April 2019) was screened using the standard 2-step method. The “after” cohort (EDD November 2019–July 2023) was screened using an expanded strategy that included the potential for GDM diagnosis based on 1–2 weeks of home glucose monitoring following isolated fasting hyperglycemia on the 3-hour glucose tolerance test (GTT). The primary outcomes were primary cesarean delivery (PCD) and neonatal intensive care unit (NICU) admission. Binomial regression and Kruskal Wallis tests were used to compare perinatal outcomes between the two cohorts in the general population and in a subgroup of those with isolated fasting hyperglycemia. Outcomes for the “before” cohort (<i>n</i> = 1,733) were compared with those in the “after” cohort (<i>n</i> = 6,280). In the general population, A2GDM incidence increased after expansion of the screening protocol (4.8% vs. 6.4%, RR 1.34, 95% CI 1.07–1.69), but PCD and NICU admission rates were unchanged. In the subgroup of patients with isolated fasting hyperglycemia (<i>n</i> = 233), there was a significant increase in the incidence of any GDM (12.5 vs. 46.0%, RR 3.68, 95% CI 1.95–6.93) and A2GDM (8.3% vs. 37.3%, RR 4.47, 95% CI 2.03–9.87). There was no difference in PCD between cohorts, but NICU admission increased significantly in the “after” cohort (8.3% vs 22.4%, RR 2.68, 95% CI 1.18–6.08) in this subgroup. An expanded approach to GDM diagnosis using home blood glucose monitoring following isolated fasting hyperglycemia on 3-hour GTT was associated with increased A2GDM incidence but no improvements in primary maternal or neonatal outcomes. In the absence of clinical benefit, we do not recommend widespread implementation of this expanded strategy.

Publication Details

Journal
Figshare
Published
2025-01-01
DOI
https://doi.org/10.6084/m9.figshare.28455404
Primary Topic
Gestational Diabetes Research and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Maternal and neonatal outcomes with different screening strategies for gestational diabetes mellitus: a retrospective cohort study

Figshare
Gestational Diabetes Research and Management
article

Maternal and neonatal outcomes with different screening strategies for gestational diabetes mellitus: a retrospective cohort study

article en

Abstract

To evaluate the effect of an expanded gestational diabetes mellitus (GDM) screening strategy on perinatal outcomes. This retrospective cohort study included gravidas screened for GDM at a single academic center. The “before” cohort (estimated due dates (EDD) March 2018–April 2019) was screened using the standard 2-step method. The “after” cohort (EDD November 2019–July 2023) was screened using an expanded strategy that included the potential for GDM diagnosis based on 1–2 weeks of home glucose monitoring following isolated fasting hyperglycemia on the 3-hour glucose tolerance test (GTT). The primary outcomes were primary cesarean delivery (PCD) and neonatal intensive care unit (NICU) admission. Binomial regression and Kruskal Wallis tests were used to compare perinatal outcomes between the two cohorts in the general population and in a subgroup of those with isolated fasting hyperglycemia. Outcomes for the “before” cohort (<i>n</i> = 1,733) were compared with those in the “after” cohort (<i>n</i> = 6,280). In the general population, A2GDM incidence increased after expansion of the screening protocol (4.8% vs. 6.4%, RR 1.34, 95% CI 1.07–1.69), but PCD and NICU admission rates were unchanged. In the subgroup of patients with isolated fasting hyperglycemia (<i>n</i> = 233), there was a significant increase in the incidence of any GDM (12.5 vs. 46.0%, RR 3.68, 95% CI 1.95–6.93) and A2GDM (8.3% vs. 37.3%, RR 4.47, 95% CI 2.03–9.87). There was no difference in PCD between cohorts, but NICU admission increased significantly in the “after” cohort (8.3% vs 22.4%, RR 2.68, 95% CI 1.18–6.08) in this subgroup. An expanded approach to GDM diagnosis using home blood glucose monitoring following isolated fasting hyperglycemia on 3-hour GTT was associated with increased A2GDM incidence but no improvements in primary maternal or neonatal outcomes. In the absence of clinical benefit, we do not recommend widespread implementation of this expanded strategy.

Figshare
Good health and well-being
Openalex Percentile: Top 46%
Gestational Diabetes Research and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Maternal and neonatal outcomes with different screening strategies for gestational diabetes mellitus: a retrospective cohort study · Figshare (2025) | TGRS Research Map | TGRS